Fennec Pharmaceuticals Statistics
NASDAQ: FENCHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
13.09-0.36 (-2.68%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Fennec Pharmaceuticals by the numbers
Fennec Pharmaceuticals has a market capitalization of $462.1 million based on 35.31M shares outstanding. Its trailing P/E ratio is 436.3, and its forward P/E is 12.5. The stock trades 21.3% above its 50-day average and 38.0% above its 200-day average.
Average daily trading volume is 220.87K shares, or about $2.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
FENC valuation vs. peer median
| Metric | FENC | Peer median | Difference |
|---|---|---|---|
| Market cap | $462.14M | $474.93M | -3% |
| Avg. volume | 220.87K | 974.35K | -77% |
Peer median across 8 companies: RGNX, SANA, DNA, VALN, IRLA, PROK, ETRA, TECX.
Valuation
- Market cap
- $462.14M
- P/E (TTM)
- 436.33
- Forward P/E
- 12.47
- Price / sales (latest FY)
- 10.35
- EPS (TTM)
- $0.03
- Shares outstanding
- 35.31M
Price and trading
- Previous close
- 13.45
- Open
- 13.15
- Day range
- 12.64 – 13.55
- 52-week range
- 5.65 – 13.85
- 52-week change
- +66.12%
- Beta
- —
- Volume
- 398.14K
- Average volume
- 220.87K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 462.14M
- Pe
- 436.33
- Forward Pe
- 12.47
- Eps
- 0.03
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 13.85
- Week52 Low
- 5.65
- Avg Volume
- 220.87K
- Shares Outstanding
- 35.31M
- Ma50
- 10.79
- Ma200
- 9.49
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -5.49%
- Pct From52w Low
- 131.68%